Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

10.83

+1.30 (13.64%)

At close: May 12, 2025, 4:00 PM

10.29

-0.54 (-4.99%)

After-hours: May 12, 2025, 4:12 PM EDT

Gyre Therapeutics Market Cap

Gyre Therapeutics has a market cap or net worth of $954.13 million as of May 12, 2025. Its market cap has decreased by -30.41% in one year.

Market Cap

954.13M

Enterprise Value

925.83M

1-Year Change

-30.41%

Ranking

#2502

Market Cap Chart

Since April 12, 2006, Gyre Therapeutics's market cap has increased from $165.40M to $954.13M, an increase of 476.86%. That is a compound annual growth rate of 9.62%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	893.50M	-21.04%
Dec 31, 2024	1.13B	1,640.92%
Dec 29, 2023	65.00M	291.57%
Dec 30, 2022	16.60M	-42.16%
Dec 31, 2021	28.70M	-79.41%
Dec 31, 2020	139.40M	70.00%
Dec 31, 2019	82.00M	-12.95%
Dec 31, 2018	94.20M	60.20%
Dec 29, 2017	58.80M	653.85%
Dec 30, 2016	7.80M	-78.21%
Dec 31, 2015	35.80M	-60.31%
Dec 31, 2014	90.20M	-35.43%
Dec 31, 2013	139.70M	-5.10%
Dec 31, 2012	147.20M	-20.82%
Dec 30, 2011	185.90M	-75.52%
Dec 31, 2010	759.30M	31.14%
Dec 31, 2009	579.00M	551.29%
Dec 31, 2008	88.90M	-49.97%
Dec 31, 2007	177.70M	2.72%
Dec 29, 2006	173.00M	4.59%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	659.45B
Johnson & Johnson	371.06B
UnitedHealth Group	345.29B
AbbVie	326.08B
Novo Nordisk	297.79B
Abbott Laboratories	231.82B
Novartis AG	214.71B
AstraZeneca	211.14B

Market Cap Rankings